CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $7.90 ($158,076)
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, FINANCE AND CAO sold 1,823 shares at $5.50 ($10,025)
- 4 Open-market sale SVP, FINANCE AND CAO sold 1,373 shares at $5.82 ($7,989)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 3,273 shares at $5.82 ($19,045)
- 4 Open-market sale PRESIDENT & CSO sold 10,758 shares at $5.82 ($62,599)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,789 shares (to pay taxes)
- 4/A Open-market buy CHIEF FINANCIAL OFFICER bought 12,000 shares at $8.53 ($102,338)
- 8-K Event Shareholder vote results
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 12,000 shares at $8.53 ($102,338)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $8.43 ($168,652)
Page 8 of 22 · 421 filings